In-depth comparison of Anc80L65 and AAV9 retinal targeting and characterization of cross-reactivity to multiple AAV serotypes in humans.
Journal Information
Full Title: Mol Ther Methods Clin Dev
Abbreviation: Mol Ther Methods Clin Dev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, Research & Experimental
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of interests K.M. is receiving royalties from Gene Therapy programs licensed to Amicus Therapeutics and Kiadis. K.M. is a scientific advisor with compensation and stock options and has received research funding from Alcyone Therapeutics."
"We would like to especially thank Dr. Luk Vandenberghe for publically providing the An80 capsid for vector generation. Thank you to SAB Tech Inc. for producing the vectors described in this study and their commitment to quality. Thank you to the Animal Resource Core at NCH for maintaining the high quality of care provided to our animals. This study was funded by internal funds of the Abigail Wexner Research Institute, Nationwide Children's Hospital."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025